Lv4
460 积分 2022-07-13 加入
Qiliqiangxin, Systolic Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction
3天前
已完结
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
1个月前
已完结
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
1个月前
已完结
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction
1个月前
已完结
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction
1个月前
已完结
Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction
1个月前
已完结
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
1个月前
已完结
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
1个月前
已完结
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
1个月前
已完结
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction
1个月前
已完结
皖公网安备34019202002308
